Plasma lipoproteins enhance tissue factor-independent factor VII activation

被引:53
作者
Kjalke, M
Silveira, A
Hamsten, A
Hedner, U
Ezban, M
机构
[1] Novo Nordisk AS, Tissue Factor Factor 7 Res, DK-2760 Malov, Denmark
[2] Karolinska Inst, Karolinska Hosp, King Gustaf V Res Inst, Atherosclerosis Res Unit, S-10401 Stockholm, Sweden
关键词
coagulation; factor VII; lipoproteins; monocytes; tissue factor;
D O I
10.1161/01.ATV.20.7.1835
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The effect of plasma lipoprotein fractions (large very-low-density lipoprotein, small very-low-density lipoprotein, intermediate-density lipoprotein, and low-density lipoprotein) on initiation of blood coagulation by supporting factor VII activation or by stimulating monocytes to express tissue factor was investigated in vitro. Endotoxin-free preparations of lipoprotein fractions did not induce functional tissue factor in monocytes, whereas all lipoprotein fractions enhanced tissue factor-independent activation of factor VII by factor Xa and by factors Xa/Va. In contrast, no or only slight enhancement of factor IXa-, factor IXa/VIIIa-, factor XIa-, or thrombin-mediated factor VII activation was observed. The effect of small very-low-density lipoprotein was less than that of large very-low-density lipoprotein, and intermediate-density and low-density lipoproteins caused an even lower but still significant increase of factor Xa- and factor Xa/Va-mediated factor VII activation. When the data were normalized for apolipoprotein B-100 content, differences remained between lipoprotein fractions. In contrast, when phospholipid content was used for normalization, differences between lipoprotein fractions in factor Xa- and factor Xa/Va-mediated factor VII activation disappeared, indicating that phospholipids were involved in factor VII activation. This was supported by enhancement of factor Xa-mediated factor VII activation by synthetic phospholipid vesicles containing negatively charged phospholipids.
引用
收藏
页码:1835 / 1841
页数:7
相关论文
共 44 条
[1]   Effects of a cardioselective β-blocker on postprandial triglyceride-rich lipoproteins, low density lipoprotein particle size and glucose-insulin homeostasis in middle-aged men with modestly increased cardiovascular risk [J].
Boquist, S ;
Ruotolo, G ;
Hellénius, ML ;
Danell-Toverud, K ;
Karpe, F ;
Hamsten, A .
ATHEROSCLEROSIS, 1998, 137 (02) :391-400
[2]   OXIDIZED LDL ENHANCES LIPOPOLYSACCHARIDE-INDUCED TISSUE FACTOR EXPRESSION IN HUMAN ADHERENT MONOCYTES [J].
BRAND, K ;
BANKA, CL ;
MACKMAN, N ;
TERKELTAUB, RA ;
FAN, ST ;
CURTISS, LK .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (05) :790-797
[3]   Kinetics of human factor VII activation [J].
Butenas, S ;
Mann, KG .
BIOCHEMISTRY, 1996, 35 (06) :1904-1910
[4]   Structural changes in factor VIIa induced by Ca2+ and tissue factor studied using circular dichroism spectroscopy [J].
Freskgard, PO ;
Olsen, OH ;
Persson, E .
PROTEIN SCIENCE, 1996, 5 (08) :1531-1540
[5]   REGULATION OF TISSUE FACTOR GENE-EXPRESSION IN THE MONOCYTE PROCOAGULANT RESPONSE TO ENDOTOXIN [J].
GREGORY, SA ;
MORRISSEY, JH ;
EDGINGTON, TS .
MOLECULAR AND CELLULAR BIOLOGY, 1989, 9 (06) :2752-2755
[6]   FIBRINOGEN AND FACTOR-VII IN THE PREDICTION OF CORONARY RISK - RESULTS FROM THE PROCAM STUDY IN HEALTHY-MEN [J].
HEINRICH, J ;
BALLEISEN, L ;
SCHULTE, H ;
ASSMANN, G ;
VANDELOO, J .
ARTERIOSCLEROSIS AND THROMBOSIS, 1994, 14 (01) :54-59
[7]  
KARPE F, 1994, J LIPID RES, V35, P1311
[8]   Amino acid residues 721-729 are required for full factor VIII activity [J].
Kjalke, M ;
Heding, A ;
Talbo, G ;
Persson, E ;
Thomsen, J ;
Ezban, M .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1995, 234 (03) :773-779
[9]  
Kjalke M, 1997, THROMB HAEMOSTASIS, V78, P1202
[10]  
LEWIS JC, 1995, AM J PATHOL, V147, P1029